Physicians

MM&M's top 5 stories in November 2016

MM&M's top 5 stories in November 2016

By

How VR, nanotechnology, and 3D printing could improve the value of healthcare; 100 experimental therapies in late-stage clinical trials; Kite Pharma plans "controlled" launch of CAR-T therapy

The doctor-patient dialogue: As productive as it's ever been or broken?

The doctor-patient dialogue: As productive as it's ever been or broken?

By

More barriers separate doctors and patients than ever before, from rising costs and time constraints to electronic health records and smartphones.

ContextMedia to acquire AccentHealth to grow its position in the point-of-care market

ContextMedia to acquire AccentHealth to grow its position in the point-of-care market

By

As part of the acquisition, 160 AccentHealth employees will join ContextMedia, which has a staff of about 500 people.

Physicians still rely on medical journals but turn to the web when they have only 10 minutes

Physicians still rely on medical journals but turn to the web when they have only 10 minutes

By

Drugmakers can do a better job of organizing dosing information, safety information, and clinical data on their brand websites, a new survey found.

Five things for pharma marketers to know: Wednesday, November 16, 2016

Five things for pharma marketers to know: Wednesday, November 16, 2016

By

The AMA votes in favor of value-based drug pricing; Amgen says insurers are balking at PCSK9 inhibitor prices; docs aren't focused on prices when prescribing

Pharma pushes to share off-label info with payers at FDA hearing

Pharma pushes to share off-label info with payers at FDA hearing

By

Insurers and pharmacy benefit managers already have a sophisticated understanding of clinical data, the industry argued.

Infographic: what information doctors need from pharma

Infographic: what information doctors need from pharma

How pharma distributes information to doctors is changing as rapidly as how doctors prefer to receive and process such information

Adding Support at the Point of Care May Also Improve Access to Docs

Adding Support at the Point of Care May Also Improve Access to Docs

It's becoming less and less likely that an in-person physician/sales rep interaction will take place at the healthcare provider's office.

Sermo and Everyday Health partner in advertising-research deal

Sermo and Everyday Health partner in advertising-research deal

By

The partnership allows Sermo to expand the reach of its research initiatives and Everyday Health to scale its targeted advertising on the social platform.

MM&M's 5 most popular stories in September 2016

MM&M's 5 most popular stories in September 2016

By

Physicians are seeking beyond-the-pill services from drugmakers; Novartis debunks misconception that only smokers get lung cancer; pharma's access to docs declines

The provider gift ban: The day the tchotchkes died

The provider gift ban: The day the tchotchkes died

By

For some people in the industry ecosystem, the appeal of promo knickknacks endures.

Lewis Miller on the Evolving CME Landscape

Lewis Miller on the Evolving CME Landscape

Rising healthcare costs, the need for team health delivery and enhanced teamwork, and empowered consumers have all played a role.

Five things for pharma marketers to know: Wednesday, September 14, 2016

Five things for pharma marketers to know: Wednesday, September 14, 2016

By

Patients who ask for a prescription after seeing an ad are more likely to get one; Mylan's executive pay is now under scrutiny

Five things for pharma marketers to know: Tuesday, September 13, 2016

Five things for pharma marketers to know: Tuesday, September 13, 2016

By

Drugmakers routinely pay ghostwriters to write industry-funded research articles; Horizon to buy Raptor for $800 million; WellDoc partners with J&J

Report: 3 tips for pharma to provide beyond-the-pill services

Report: 3 tips for pharma to provide beyond-the-pill services

By

Physicians are seeking beyond-the-pill services from drugmakers, but few sales reps shares details with docs about these programs, a new report finds.

Data, Technology, and Medicine: How They Intersect

Data, Technology, and Medicine: How They Intersect

By

The intersection of data, technology, and medicine is rapidly changing how doctors practice, drug companies market, and patients engage with the healthcare system.

Infographic: How physicians share online info with patients and other docs

Infographic: How physicians share online info with patients and other docs

The availability of online medical information is changing the way doctors share and receive information — both among themselves and with their patients.

Five things for pharma marketers to know: Friday, August 19, 2016

Five things for pharma marketers to know: Friday, August 19, 2016

By

Another study finds doctors who receive gifts from drugmakers prescribe their drugs; Part D spending rose 17% in 2014; Mallinckrodt to open New Jersey site

Event company acquires AstraZeneca's medical meetings app

Event company acquires AstraZeneca's medical meetings app

By

The event technology platform plans to integrate a conference note-taking app developed by AstraZeneca and DigitasLBi.

How Insights from Patients Can Shape Medical Practice and Communication

How Insights from Patients Can Shape Medical Practice and Communication

Many patients find it difficult to ask questions of their physician.

No free lunch for docs: Sponsored meals linked to more prescriptions

No free lunch for docs: Sponsored meals linked to more prescriptions

By

A new analysis suggests that $20 industry-sponsored meals may sway docs' prescribing habits.

Five things for pharma marketers to know: Tuesday, June 14, 2016

Five things for pharma marketers to know: Tuesday, June 14, 2016

By

Physicians debate DTC tax write-off; Novo Nordisk's Victoza shows 13% benefit in reducing cardiovascular risks; Shire to acquire Pfizer bowel drug

Leadership Exchange: Engaging the Millennial Doctor

Leadership Exchange: Engaging the Millennial Doctor

By

In partnership with inVentiv Health, MM&M found a millennial doctor to ask about her frustrations with the existing pharma marketing model to her willingness to text patients.

Merck educates doctors about biosimilars, long before it will sell one in the U.S.

Merck educates doctors about biosimilars, long before it will sell one in the U.S.

By

Drugmakers like Merck are making a big education push as they lay the groundwork for future biosimilars.

What do physicians think about biosimilars?

What do physicians think about biosimilars?

By

A Sermo poll asked physicians: Do you feel biosimilars will prove safe and effective enough for you to prescribe them when more become available?"

Five things for pharma marketers to know: Tuesday, May 17, 2016

Five things for pharma marketers to know: Tuesday, May 17, 2016

By

Online doctors prescribe drugs without adequate warnings; House lawmakers to discuss Part B proposal; obesity drugs struggle for market share

DTC Report 2016: Gut Check

DTC Report 2016: Gut Check

By

DTC is facing a new test from physicians and politicians. Here's why critics fear a deluge, and how they're pushing back.

Another physician group raises concerns about DTC

Another physician group raises concerns about DTC

By

The American College of Physicians questioned the role direct-to-consumer advertising plays in contributing to prescription drug costs.

How My GI Health changed the conversation for patients

How My GI Health changed the conversation for patients

By

The motivating force behind My GI Health met initial resistance. After all, it came from a company executive who professed that his goal was to benefit all companies within that therapeutic area.

Ironwood's McCourt bets big on data and the patient-physician dialogue

Ironwood's McCourt bets big on data and the patient-physician dialogue

By

Tom McCourt says he's "a marketing guy who hopefully understands a little about drug development" even as he guided drugs like Prilosec to market.

OPINION

Email Newsletters